ZIP14 is a transmembrane metal ion transporter that is abundantly expressed in the liver, heart, and pancreas. Previous studies of HEK 293 cells and the hepatocyte cell lines AML12 and HepG2 established that ZIP14 mediates the uptake of nontransferrin-bound iron, a form of iron that appears in the plasma during pathologic iron overload. In this study we investigated the role of ZIP14 in the cellular assimilation of iron from transferrin, the circulating plasma protein that normally delivers iron to cells by receptor-mediated endocytosis. We also determined the subcellular localization of ZIP14 in HepG2 cells. We found that overexpression of ZIP14 in HEK 293T cells increased the assimilation of iron from transferrin without increasing levels of transferrin receptor 1 or the uptake of transferrin. To allow for highly specific and sensitive detection of endogenous ZIP14 in HepG2 cells, we used a targeted knock-in approach to generate a cell line expressing a FLAG-tagged ZIP14 allele. Confocal microscopic analysis of these cells detected ZIP14 at the plasma membrane and in endosomes containing internalized transferrin. HepG2 cells in which endogenous ZIP14 was suppressed by siRNA assimilated 50% less iron from transferrin compared with controls. The uptake of transferrin, however, was unaffected. We also found that ZIP14 can mediate the transport of iron at pH 6.5, the pH at which iron dissociates from transferrin within the endosome. These results suggest that endosomal ZIP14 participates in the cellular assimilation of iron from transferrin, thus identifying a potentially new role for ZIP14 in iron metabolism.
Most cells acquire iron from transferrin (TF),2 a circulating plasma protein that can carry up to two ferric (Fe 3ϩ ) iron atoms. After Fe-TF binds to cell surface TF receptor 1 (TFR1), the plasma membrane invaginates into clathrin-coated pits, which internalize the Fe-TF⅐TFR1 complex into endosomes. Upon endosomal acidification, Fe 3ϩ is released and subsequently reduced to Fe 2ϩ . The liberated Fe 2ϩ is then transported across the endosomal membrane and into the cytosol (1).The assimilation of iron from TF has been best characterized in developing erythroid cells, the most avid consumers of TFbound iron (TBI). In these cells, reduction of Fe 3ϩ is catalyzed by the oxidoreductase Steap3 (2), and iron transport out of the endosome is facilitated by the transmembrane protein divalent metal transporter 1 (DMT1) (3, 4). Accordingly, mice lacking either Steap3 or DMT1 cannot incorporate sufficient iron into developing erythrocytes and become anemic (2, 3). After the erythroid marrow, the second largest consumer of TBI is the liver, accounting for 10 -20% of iron exchange with the plasma (5). Interestingly, anemic Steap3-mutant mice or DMT1-null mice are able to take up iron into the liver (6, 7), indicating that Steap3 and DMT1 are dispensable for hepatic iron uptake.Under normal conditions, Ͼ95% of plasma iron is TBI. Studies in perfused rat liver document that the liver takes up TBI, almost exclusively into he...